Abionyx Pharma (XPAR:ABNX) Institutional Ownership : 0.03% (As of Jun. 19, 2024)

View and export this data going back to 2015. Start your Free Trial

What is Abionyx Pharma Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Abionyx Pharma's institutional ownership is 0.03%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Abionyx Pharma's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Abionyx Pharma's Float Percentage Of Total Shares Outstanding is 0.00%.

Abionyx Pharma Institutional Ownership Historical Data

The historical data trend for Abionyx Pharma's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abionyx Pharma Institutional Ownership Chart

Abionyx Pharma Historical Data

The historical data trend for Abionyx Pharma can be seen below:

	2022-11-30	2022-12-31	2023-01-31	2023-02-28	2023-03-31	2023-04-30	2023-10-31	2023-11-30	2023-12-31	2024-01-31
Institutional Ownership	0.03	0.03	0.05	0.02	0.04	0.02	0.03	0.03	0.03	0.03

Abionyx Pharma Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

Abionyx Pharma (XPAR:ABNX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Abionyx Pharma (XPAR:ABNX) » Definitions » Institutional Ownership

Comparable Companies

Traded in Other Exchanges

609:Germany

Address

33-43 Avenue Georges Pompidou-Bat D2, Balma, FRA, 31130

Website

https://www.abionyx.com

Abionyx Pharma is a new generation biotech company dedicated to the discovery and development of innovative therapies for patients without existing or effective treatment. The biotech assets inherited from CERENIS Therapeutics constitute a portfolio of valuable programs for the treatment of cardiovascular diseases and associated metabolic diseases such as NAFLD and NASH as well as an HDL targeted drug delivery platform in oncology, more specifically in Immuno oncology and chemotherapy.

Abionyx Pharma (XPAR:ABNX) Headlines

No Headlines